DeutschNewstral
Article
Merced Sun-Star on 2023-10-26 04:34
Eisai Alzheimer’s Drug Shows Promise in Injected-At-Home Form
Related news
Eisai shares jump after FDA approves Alzheimer’s drug lecanemabThe Japan Times- Biogen and Eisai revive plans for Alzheimer’s drug aducanumab, but prospects still shakyThe Japan Times
- U.S. approves Eisai and Biogen’s drug to slow Alzheimer’s diseaseThe Japan Times
Eisai Co Ltd: Japan’s Eisai aims to silence critics over breakthrough Alzheimer’s drugFinancial Times- BAlzheimer’s progression slowed by drug in major trialbloomberg.com
Alzheimer’s drug shows promise in human trialsFOX 8 News Cleveland
New drug shows promise in treating Alzheimer’spunchng.com- FBiogen’s Alzheimer’s drug shows early promiseft.com
Report
Biogen’s Alzheimer’s drug shows early promiseReuters- Alzheimer’s drug made jointly by Japan’s Eisai wins accelerated U.S. approvalThe Japan Times
- MAlzheimer’s drug Leqembi exhibits promise as injectionmvtelegraph.com
- Eisai and Biogen apply for approval of Alzheimer’s drug in JapanThe Japan Times
China joins US and Japan in approving Alzheimer’s drug Leqembi developed by Eisai and BiogenSouth China Morning Post- Eisai sees potential of new Alzheimer’s drug but costs remain concernThe Japan Times
- Priority review status given to Alzheimer’s drug developed by Eisai and BiogenThe Japan Times
After US approval, Japan OKs Leqembi, its first Alzheimer’s drug, developed by Eisai and BiogenSeattle Times- Dementia: Eisai says Alzheimer’s drug did not cause deaths of trial patientsFinancial Times
- Eisai Alzheimer’s drug sparks debate over benefits as risks like brain bleeding emergeThe Japan Times
- BBiogen and Eisai Strengthen Lead in Alzheimer’s Drug Race. The Stocks Are Rising. 2 min readbarrons.com